Analysis of endoscopic and histologic assessment of early Barrett’s neoplasia by tertiary referring centres with chromoendoscopy – an international comparison

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00003079

Enrollment

Registered

2011-07-14

Start date

2011-07-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Barrett neoplasia, barrett carcinoma C15.9

Interventions

Group 1: Non-interventional group: 1. recording of the endoscopy of the early Barrett's neoplasia 2. Scanning of the histological slides in order to obtain high resolution electronic pictures 3. Asses

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. patients older than 18 years 2. patients with assumed or previous confirmed Barrett’s neoplasia 3. patients having a good general condition feasible for endoscopic resection

Exclusion criteria

Exclusion criteria: 1. missing consent/agreement 2. patients with confirmed late stage malignancy 3. acute reflux esophagitis 4. endoscopic pre-treatment of the lesion 5. patients with coagulopathy or anti coagulative medication (e.g. clopidogrel, coumadin)

Design outcomes

Primary

Measure	Time frame
Agreement between macroscopic diagnosis made by endoscopists and histologic diagnosis made by pathologist in different centers from different countries	—

Secondary

Measure	Time frame
Agreement between histologic and macroscopic diagnosis	—

Countries

Germany

Contacts

Public ContactOliver Pech

Innere Medizin 2, HSK Wiesbaden

oliver.pech@hsk-wiesbaden.de0611432420

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026